H1B Salary Data

Home › Employers › Clinical Resolution Laboratory, Inc.

Clinical Resolution Laboratory, Inc.: H-1B salaries and sponsorship

Clinical Resolution Laboratory, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $120,286.

Applications (LCAs)3
Certified3
Employer addressBrea, CA
H-1B dependent employerNo
Median offered salary$120,286
Middle half of salaries$95,524–$130,530
10th–90th percentile$80,667–$136,676

Does Clinical Resolution Laboratory, Inc. sponsor H-1B visas?

Clinical Resolution Laboratory, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 30, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Logistics Analyst1$70,762
Quality Assurance Engineer1$140,774
Supply Chain Manager1$120,286

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$70,762
FY20262$130,530

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Quality Assurance Engineer$140,774–$140,816
Level IV
Brea, CAMay 30, 2026Oct 1, 2026Certified
Supply Chain Manager$120,286–$120,328
Level III
Brea, CAMay 30, 2026Oct 1, 2026Certified
Logistics Analyst$70,762
Level II
Brea, CAAug 30, 2023Oct 7, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).